Dai Dai

145 Shan Dong Middle Road
Shanghai, 200001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Reply.

Reply.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: January 10, 2026

Low-Grade Proteinuria Does Not Predict Favorable Outcomes in Lupus Nephritis: A Longitudinal Cohort Study.

Low-Grade Proteinuria Does Not Predict Favorable Outcomes in Lupus Nephritis: A Longitudinal Cohort Study.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: July 18, 2025

Association between serum Copper-Zinc-Selenium mixture and multiple health outcomes.

Association between serum Copper-Zinc-Selenium mixture and multiple health outcomes.

Journal: Bioactive materials

Published: February 07, 2025

IL-2 signalling sustains pathogenic age-associated B cell homeostasis in lupus.

IL-2 signalling sustains pathogenic age-associated B cell homeostasis in lupus.

Journal: Annals of the rheumatic diseases

Published: December 17, 2024

The transcription factor ZEB2 drives the formation of age-associated B cells.

The transcription factor ZEB2 drives the formation of age-associated B cells.

Journal: Science (New York, N.Y.)

Published: January 25, 2024

Novel potential lncRNA biomarker in B cells indicates essential pathogenic pathway activation in patients with SLE.

Novel potential lncRNA biomarker in B cells indicates essential pathogenic pathway activation in patients with SLE.

Journal: Lupus science & medicine

Published: September 28, 2023

Involvement of Transcriptional Factor Pbx1 in Peripheral B Cell Homeostasis to Constrain Lupus Autoimmunity.

Involvement of Transcriptional Factor Pbx1 in Peripheral B Cell Homeostasis to Constrain Lupus Autoimmunity.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: July 13, 2022

Rapamycin-encapsulated costimulatory ICOS/CD40L-bispecific nanoparticles restrict pathogenic helper T-B-cell interactions while in situ suppressing mTOR for lupus treatment.

Rapamycin-encapsulated costimulatory ICOS/CD40L-bispecific nanoparticles restrict pathogenic helper T-B-cell interactions while in situ suppressing mTOR for lupus treatment.

Journal: Biomaterials

Published: March 22, 2022

Novel Mutations in ACP5 and SAMHD1 in a Patient With Pediatric Systemic Lupus Erythematosus.

Novel Mutations in ACP5 and SAMHD1 in a Patient With Pediatric Systemic Lupus Erythematosus.

Journal: Frontiers in pediatrics

Published: February 27, 2022

Amelioration of Autoimmunity in a Lupus Mouse Model by Modulation of T-Bet-Promoted Energy Metabolism in Pathogenic Age/Autoimmune-Associated B Cells.

Amelioration of Autoimmunity in a Lupus Mouse Model by Modulation of T-Bet-Promoted Energy Metabolism in Pathogenic Age/Autoimmune-Associated B Cells.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: January 10, 2022

SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expression.

SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expression.

Journal: Nature communications

Published: March 24, 2020

The MicroRNA miR-22 Represses Th17 Cell Pathogenicity by Targeting PTEN-Regulated Pathways.

The MicroRNA miR-22 Represses Th17 Cell Pathogenicity by Targeting PTEN-Regulated Pathways.

Journal: ImmunoHorizons

Published: January 29, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026